Global Cognitive and Memory Enhancer Drugs Market Size, Share, Growth Analysis Report - Forecast 2034

Cognitive and Memory Enhancer Drugs Market Size

The global cognitive and memory enhancer drugs market size was worth around USD 5.93 Billion in 2024 and is predicted to grow to around USD 9.94 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 5.3% between 2025 and 2034.

The report analyzes the global cognitive and memory enhancer drugs market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the cognitive and memory enhancer drugs industry.

Request Free Sample

Cognitive and Memory Enhancer Drugs Market: Overview

Cognition is the process of mentally acquiring knowledge and understanding through experiences, senses, or thoughts. Cognitive and memory enhancer drugs or external supplements are intended to improve the cognitive capacity of an individual which includes executive functions like creativity, motivation, attention, and memory. These drugs are used for patients who face difficulty in maintaining an optimum level of cognitive functions. Patients who suffer from mental health issues like Alzheimer’s, Schizophrenia, Paranoia, and ADD are treated with these drugs to help them cope with the effects of the disorder.

For desired and optimum results, cognitive & memory enhancer drugs should be prescribed by certified medical practitioners. This is because the drugs have extreme potential and only the right dosage of these supplements can provide the patients with positive outcomes.

The market witnessed a slight decline in the years 2020 and 2021. One of the major reasons was Covid-19 and its impact. Some of the other reasons include the ill effects of mixing multiple types of medicines, given the unpredictable situations that arose due to Covid-19.

However, the market has grown steadily over the last couple of years and is showing signs of growth in the coming future. The global market is one of the most critical markets given the type of sensitivity these drugs and supplements deal with.

Key Insights

• As per the analysis shared by our research analyst, the global cognitive and memory enhancer drugs market is estimated to grow annually at a CAGR of around 5.3% over the forecast period (2025-2034).
• Regarding revenue, the global cognitive and memory enhancer drugs market size was valued at around USD 5.93 Billion in 2024 and is projected to reach USD 9.94 Billion by 2034.
• The cognitive and memory enhancer drugs market is projected to grow at a significant rate due to increasing demand for nootropics, rising prevalence of neurodegenerative disorders, advancements in neuroscience research, and growing aging population.
• Based on Drug Type, the Aricept segment is expected to lead the global market.
• On the basis of Application, the Disease Treatment segment is growing at a high rate and will continue to dominate the global market.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Request Free Sample

Cognitive and Memory Enhancer Drugs Market: Growth Drivers

An increase in the geriatric population & neurological diseases is a leading global market growth driver

Geriatric refers to the population that suffers from declining health because of old age.

A general increase in the number of geriatric patients is one of the potential growth propellers for the global market. As per a report submitted by WHO, around 46 million of the world population suffer from dementia, a disorder related to memory.

The number of elderly people suffering from Alzheimer's has increased over the years. Along with this, neurological disorders have been on a constant rise. These factors eventually push the global cognitive and memory enhancer drugs market forward.

Increasing awareness of mental health is a recent but major reason for global market growth

With discussions over mental health now taking the front row, awareness about the same has been at an all-time high. Along with this comes the need to treat these disorders driving the global market. Positive effects owing to cognitive & memory enhancer drugs are a contributing factor in the growth of the global market.

The cognitive & memory enhancer drugs have proven to be effective in treating multiple disorders. Patients or users have shown improved physical and mental health causing a high acceptance rate amongst the general population and acting as a global market driver.

Anticipation for upcoming drugs and supplements will boost the global market growth

New developments in R&D and the production of better quality drugs or supplements are predicted to boost the global market growth in the coming years. The newer drugs are anticipated to have lesser side effects while providing better results. 

Cognitive and Memory Enhancer Drugs Market: Restraints

The unethical use of cognitive and memory enhancer drugs restricts the global market growth

Unethical use means the use of drugs without proper medical consultation. The increase in the number of unethical use reported across the globe is a major restraining factor in global market growth. Contradictions related to ethical and unethical use of cognitive & memory enhancer drugs also contribute to restricting the global market from growing.

The high cost of R & D prohibits market growth

The investment required for the research and development of newer or better supplements is very high. This restricts the capacity of drug producers from taking one step forward in the global cognitive and memory enhancer drugs market.

Cognitive and Memory Enhancer Drugs Market: Opportunities

Increase in neurological disorders to fuel growth opportunities in the global market

A tremendous increase in detection and treatment of neurological disorders combined with an increasing number of geriatric patients is predicted to expand the growth opportunities for the global market.

Untapped potential of medical drugs and supplements is a great opportunity to be explored.

The current global market situation is only the tip of the iceberg. The underlying potential of the global market is yet to be tapped which requires rigorous scientific research and development. With better investments, the global market has exceptional growth opportunities.

Increase in medical facilities holds a large number of growth opportunities for the global market.

With the increasing number of medical facilities that provide cognitive and memory enhancer drugs, more patients will have access to the care they need. The easy accessibility to the necessary supplements can create a growth path for the global market.

Cognitive and Memory Enhancer Drugs Market: Challenges

Managing the unethical practices is a major concern in the global market

One of the major challenges the global market has to overcome is the management of unethical practices and ethical contradictions that take place globally. Stricter rules to stop the unethical use of drugs are needed to overcome the challenge. Along with this more efforts need to be put in the direction of ethical practices.

High cost of production of drugs & supplements can hamper the growth of the global market

Medicinal drugs are expensive in many countries and require huge investment for production. This poses a challenge to the global reach of cognitive and memory enhancer drugs. Tracking the expense and keeping it under control is a challenging factor in the global market.

Cognitive and Memory Enhancer Drugs Market: Segmentation Analysis

The global cognitive and memory enhancer drugs market is segmented based on Drug Type, Application, and region.

Based on Drug Type, the global cognitive and memory enhancer drugs market is divided into Aricept, Razadyne, Namenda, Exelon, Provigil, Ritalin, Adderall, and Others.

On the basis of Application, the global cognitive and memory enhancer drugs market is bifurcated into Disease Treatment, Academic Performance, Athletic Performance, and Others.

Cognitive and Memory Enhancer Drugs Market: Report Scope

Recent Developments

• In September 2021, a Bristol-led study recognized certain drug targets in the neural circuits that encipher memories, making a path for noteworthy developments in treating a wide array of brain disorders.
• In April 2022, a first-in-class oral compound aiming NMDA (N-methyl-D-aspartate) receptors turned out to be useful in a mid-stage clinical trial for Alzheimer's disease, creating the base for a complete efficacy and safety study. A PAM (positive allosteric modulator) of NMDA receptor activity, SAGE-718, enhanced mean scores on 5 standard memory tests in twenty-six Alzheimer's patients suffering from mild cognitive deficits.

Cognitive and Memory Enhancer Drugs Market: Regional landscape

North America leads the global cognitive and memory enhancer drugs market. The reasons for this lead are the increasing number of patients suffering from Alzheimer's along with the rising older population. The increased investment in novel products is also a leading cause for North America to become a global market leader.

North America is followed by Europe which is also seen investing heavily in the global market share. Europe is attributed with a relatively higher standard of healthcare making it a leading contributor to the global market.

From the emerging markets, Asia Pacific has been showing a growing trend towards contributing to the market given its rising concern for healthcare and it is expected to grow at the highest CAGR during the forecast period. This is owed to the increase in patients needing cognitive and memory enhancer drugs.

Latin America & Middle East have been showing a moderate contribution to the global market.

Cognitive and Memory Enhancer Drugs Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the cognitive and memory enhancer drugs market on a global and regional basis.

The global cognitive and memory enhancer drugs market is dominated by players like:

• Johnson and Johnson Services
• Teva Pharmaceutical Industries Ltd
• AbbVie
• Lundbeck
• Eisai Co Ltd
• Lilly
• Sanofi
• Takeda Pharmaceutical Company Ltd
• Novartis AG
• Pfizer
• Biogen
• Torrent Pharmaceutical Inc

The global cognitive and memory enhancer drugs market is segmented as follows;

By Drug Type

• Aricept
• Razadyne
• Namenda
• Exelon
• Provigil
• Ritalin
• Adderall
• and Others

By Application

• Disease Treatment
• Academic Performance
• Athletic Performance
• and Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America